BioSpace News Archive

Caeregen Therapeutics, a regenerative medicine therapeutics company and Wacker Biotech, a contract development and manufacturing organization, will collaborate on the development and production of CTR-107, a novel regenerative therapeutic for the treatment of retinal-related vision loss.

Pfizer Inc. and OPKO Health Inc. announced that the U.S. Food and Drug Administration has approved NGENLA, a once-weekly, human growth hormone analog indicated for treatment of pediatric patients aged three years and older who have growth failure due to inadequate secretion of endogenous growth hormone.

NovaBay® Pharmaceuticals, Inc. announces that it will be sponsoring dry eye educational programs and offering special promotions on its Avenova®-branded eyecare products to customers and eyecare professionals throughout July in support of National Dry Eye Awareness Month.

First Wave BioPharma, Inc. today announced that the final patient was dosed in the Phase 2 SPAN clinical trial investigating an enhanced enteric microgranule delivery formulation of adrulipase for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF).

Triple Hair Group Inc. (“Triple Hair” or the “Company”), a global leader in the development of innovative treatments for alopecia, is pleased to announce that it has received a No Objection Letter from Health Canada, allowing it to move forward with its Phase III clinical trials on its flagship prescription product Therapy-07 in Canada.

Chemomab Therapeutics Ltd. today announced the publication of a peer-reviewed research article describing how CCL24 is a key driver of the fibrotic and inflammatory disease processes that result in primary sclerosing cholangitis (PSC), a rare disease of the bile ducts that has no FDA-approved treatments and is often fatal.

Roivant (Nasdaq: ROIV) today reported its financial results for the fourth quarter and fiscal year ended March 31, 2023, and provided an update on the business.

Mednow Inc. (“ Mednow '' or the “ Company ”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company will be hosting its quarterly conference call on Friday, June 30, 2023 at 8:30am EST.

Orthofix Medical Inc., a leading global spine and orthopedics company, announced the launch of the TrueLok™ Phantom and Tornado Hinges, the latest addition to the Orthopedics TrueLok circular frame portfolio.

AMRA researchers together with Linköping University used personalized imaging-derived obesity phenotypes, based on a large, population-based study, to investigate cardiometabolic risk stratification in individuals with obesity.